miR-181c promotes proliferation via suppressing PTEN expression in inflammatory breast cancer
miR-181c promotes proliferation via suppressing PTEN expression in inflammatory breast cancer
复制标题
DOI：
10.3892/ijo.2015.2896
复制
发表时间：
2015-05-01
影响因子：
5.2
通讯作者：
Zhang, Jian-Hua
中科院分区：
文献类型：
--
作者：
Zhang, Wen-Long;Zhang, Jian-Hua
原发性炎症性乳腺癌 (IBC) 约占新发乳腺癌病例的 6%。即使采用多模式治疗，5 年无病生存期仍为
Primary inflammatory breast cancer (IBC) accounts for similar to 6% of new breast cancer cases. Even with multi-modality treatment, the 5-year disease-free survival is